Published in Magn Reson Med on March 01, 2009
Dual-band water and lipid suppression for MR spectroscopic imaging at 3 Tesla. Magn Reson Med (2010) 0.98
Improved spatial coverage for brain 3D PRESS MRSI by automatic placement of outer-volume suppression saturation bands. J Magn Reson Imaging (2011) 0.83
Proton magnetic resonance spectroscopy: technique for the neuroradiologist. Neuroimaging Clin N Am (2013) 0.79
Automated prescription of oblique brain 3D magnetic resonance spectroscopic imaging. Magn Reson Med (2012) 0.78
Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm [NMR imaging]. IEEE Trans Med Imaging (1991) 4.97
Regularized higher-order in vivo shimming. Magn Reson Med (2002) 2.83
Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med (2001) 2.47
Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med (2000) 2.45
Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol (2001) 2.34
Multisection proton MR spectroscopic imaging of the brain. Radiology (1993) 2.19
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med (1996) 1.71
Optimized outer volume suppression for single-shot fast spin-echo cardiac imaging. J Magn Reson Imaging (1998) 1.66
In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging (2002) 1.32
Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology (1992) 1.28
Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T. Magn Reson Imaging (2006) 1.06
Short echo time proton MR spectroscopic imaging. J Comput Assist Tomogr (1993) 1.05
3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil. J Magn Reson Imaging (2007) 1.02
SELOVS: brain MRSI localization based on highly selective T1- and B1- insensitive outer-volume suppression at 3T. Magn Reson Med (2008) 0.95
Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors. NMR Biomed (1998) 0.90
Reduced power selective excitation radio frequency pulses. Magn Reson Med (1994) 0.88
Efficient design of pulses with trapezoidal magnitude and linear phase response profiles. Magn Reson Med (1997) 0.82
Band-selective spin echoes for in vivo localized 1H NMR spectroscopy. Magn Reson Med (1994) 0.81
Sparse MRI: The application of compressed sensing for rapid MR imaging. Magn Reson Med (2007) 22.30
Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (2011) 5.53
Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res (2008) 4.79
Abnormal brain development in newborns with congenital heart disease. N Engl J Med (2007) 4.55
SPIRiT: Iterative self-consistent parallel imaging reconstruction from arbitrary k-space. Magn Reson Med (2010) 4.33
Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate. Sci Transl Med (2013) 4.23
Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience. Magn Reson Med (2007) 4.13
Control over brain activation and pain learned by using real-time functional MRI. Proc Natl Acad Sci U S A (2005) 3.66
Q-ball reconstruction of multimodal fiber orientations using the spherical harmonic basis. Magn Reson Med (2006) 3.35
Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson (2007) 3.35
Saturated double-angle method for rapid B1+ mapping. Magn Reson Med (2006) 3.15
Rapid gridding reconstruction with a minimal oversampling ratio. IEEE Trans Med Imaging (2005) 3.11
Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol (2008) 2.65
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging (2002) 2.64
Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr (2005) 2.63
Diffusion tensor imaging: serial quantitation of white matter tract maturity in premature newborns. Neuroimage (2004) 2.58
Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med (2005) 2.55
Registration-based approach for reconstruction of high-resolution in utero fetal MR brain images. Acad Radiol (2006) 2.43
Metal-induced artifacts in MRI. AJR Am J Roentgenol (2011) 2.42
Compressed sensing for resolution enhancement of hyperpolarized 13C flyback 3D-MRSI. J Magn Reson (2008) 2.39
Design of flyback echo-planar readout gradients for magnetic resonance spectroscopic imaging. Magn Reson Med (2005) 2.33
Referenceless PRF shift thermometry. Magn Reson Med (2004) 2.31
Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med (2004) 2.16
Quantitative diffusion tensor MRI fiber tractography of sensorimotor white matter development in premature infants. Neuroimage (2005) 2.13
Flexible real-time magnetic resonance imaging framework. Conf Proc IEEE Eng Med Biol Soc (2004) 2.11
Learned regulation of spatially localized brain activation using real-time fMRI. Neuroimage (2004) 2.08
ESPIRiT--an eigenvalue approach to autocalibrating parallel MRI: where SENSE meets GRAPPA. Magn Reson Med (2014) 2.06
Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. J Magn Reson (2009) 2.05
13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. Cell Metab (2011) 2.05
Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magn Reson Med (2006) 2.04
Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonography findings. AJNR Am J Neuroradiol (2003) 2.01
Improved pediatric MR imaging with compressed sensing. Radiology (2010) 1.98
SEMAC: Slice Encoding for Metal Artifact Correction in MRI. Magn Reson Med (2009) 1.98
Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro Oncol (2010) 1.97
Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J Magn Reson Imaging (2002) 1.96
3D compressed sensing for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to transgenic mouse models of cancer. Magn Reson Med (2010) 1.92
Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues. Magn Reson Med (2003) 1.89
Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage (2007) 1.88
Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. J Magn Reson (2010) 1.84
DWI of the spinal cord with reduced FOV single-shot EPI. Magn Reson Med (2008) 1.82
Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart. Eur J Heart Fail (2012) 1.82
Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. Cancer Res (2010) 1.81
Rapid multislice imaging of hyperpolarized 13C pyruvate and bicarbonate in the heart. Magn Reson Med (2010) 1.80
Nonlinear phase correction for navigated diffusion imaging. Magn Reson Med (2003) 1.70
Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med (2008) 1.69
Fast dynamic 3D MR spectroscopic imaging with compressed sensing and multiband excitation pulses for hyperpolarized 13C studies. Magn Reson Med (2010) 1.67
Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging. J Magn Reson Imaging (2011) 1.65
Investigation of tumor hyperpolarized [1-13C]-pyruvate dynamics using time-resolved multiband RF excitation echo-planar MRSI. Magn Reson Med (2010) 1.64
Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies. Magn Reson Imaging (2008) 1.64
Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson (2008) 1.64
Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging (2005) 1.63
Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. J Magn Reson (2008) 1.62
Brain injury and development in newborns with critical congenital heart disease. Neurology (2013) 1.61
In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate. Mol Imaging Biol (2009) 1.61
Monitoring urea transport in rat kidney in vivo using hyperpolarized ¹³C magnetic resonance imaging. Am J Physiol Renal Physiol (2012) 1.60
Ensuring safety of implanted devices under MRI using reversed RF polarization. Magn Reson Med (2010) 1.58
Assessment of metastatic cervical adenopathy using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol (2003) 1.58